Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.5% of adults in Aurora have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Census population 386,261. Colorado Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Aurora clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Aurora storefront.
Knee Joint Biologic Injections in Aurora, CO for clinics & physicians. Biologic injections for knee pain a… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 9.5% of adults in Aurora have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Census city-proper population is 386,261. If you are adding knee joint biologic injections, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Knee Joint Biologic Injections notes (how the product actually works)JH reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Aurora is 9.5% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 16.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 9.5% of adults — 2.5 points below the U.S. 12% figure. Obesity is 29.1%; arthritis is 21.4%. That is place-level BRFSS modeling, not a clinic census and not a Aurora trial.
Colorado is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Colorado.
Colorado is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
If you operate in Colorado and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Aurora tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Aurora, CO.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Aurora is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Aurora — 2.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Colorado Part B wound biologics follow this contractor (siblings: AR, LA, MS, NM, OK, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Aurora. Useful for joint-program math; still needs a diagnosis and privileging.
No Aurora storefront. Joe Bradley is an active practice owner. knee joint biologic injections stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.